OrbiMed’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,369
Closed -$208K 125
2022
Q4
$208K Sell
27,369
-90,086
-77% -$686K ﹤0.01% 114
2022
Q3
$960 Buy
+117,455
New +$960 0.02% 124
2021
Q3
Sell
-350,000
Closed -$7.95M 175
2021
Q2
$7.95M Buy
+350,000
New +$7.95M 0.08% 135